Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.
Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B; PROWESS Investigators.
Angus DC, et al. Among authors: basson br.
Crit Care Med. 2003 Jan;31(1):1-11. doi: 10.1097/00003246-200301000-00001.
Crit Care Med. 2003.
PMID: 12544986
Clinical Trial.